Novel use of IL-1beta compounds

Details for Australian Patent Application No. 2006306280 (hide)

Owner Novartis AG

Inventors Mundel, Trevor; Wright, Timothy; Lowe, Phil; Jung, Thomas; Gram, Hermann

Agent Davies Collison Cave

Pub. Number AU-B-2006306280

PCT Pub. Number WO2007/050607

Priority 60/742,125 02.12.05 US; 60/730,435 26.10.05 US

Filing date 24 October 2006

Wipo publication date 3 May 2007

Acceptance publication date 17 June 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/050607 Priority application(s): WO2007/050607

17 June 2010 Application Accepted

  Published as AU-B-2006306280

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306302-Methods and tools for delivery of spinal motion preservation assemblies

2006306241-Dietary fiber formulation and method of administration